P3 Health Partners Inc.
PIII
$6.68
$0.335.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 65.06% | -26.03% | -286.96% | 35.72% | 26.56% |
| Total Depreciation and Amortization | -0.48% | -2.40% | -0.09% | 0.71% | -0.44% |
| Total Amortization of Deferred Charges | -- | 469.23% | -- | -- | -- |
| Total Other Non-Cash Items | 30.13% | 2.34% | -72.24% | 5.77% | 37.40% |
| Change in Net Operating Assets | -108.24% | -47.27% | 576.80% | 21.74% | -82.47% |
| Cash from Operations | 41.53% | -153.06% | -120.84% | 48.87% | -26.15% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -103.17% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -103.17% | -- | -- | -- |
| Total Debt Issued | -50.62% | -- | -100.00% | 26.36% | -- |
| Total Debt Repaid | 98.84% | -4,604.65% | -2.13% | -41.86% | -- |
| Issuance of Common Stock | -- | -- | -- | 127,881.82% | -- |
| Repurchase of Common Stock | -- | 97.02% | -5,603.33% | 58.90% | 89.02% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4,533.33% | 98.03% | 66.59% | -- | -- |
| Cash from Financing | -9.08% | 1,456.28% | -104.43% | 392.40% | 1,457.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 88.29% | -137.49% | -122.01% | 631.89% | 47.72% |